December 2, 2024

Himedia Fd285

Tissue and Cell Extraction and Purification

EP10011 100 Tests
EUR 763.2

Himedia Chemicals Laboratories manufactures the himedia fd285 reagents distributed by Genprice. The Himedia Fd285 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact himedia chemicals. Other Himedia products are available in stock. Specificity: Himedia Category: Fd285

JBS True Blue

300 µl
EUR 16
Description: JBS True Blue

True north Cryobox1.5/2mLNatural

PK10
EUR 129.6

True Blue Diaceturate Salt

100mg
EUR 15000
Description: 108321-12-6

True Blue (TB) Diaceturate Salt

1mg Ask for price
Description: 108321-12-6

True Blue (TB) Diaceturate Salt

5mg Ask for price
Description: 108321-12-6

Goat True insulin ELISA kit

96T
EUR 700
Description: ELISA

Porcine True insulin ELISA kit

96T
EUR 700
Description: ELISA

Biology information

FD-838

TBP04351 5mg
EUR 1442.4

FD-211

T36693-10mg 10mg Ask for price
Description: FD-211

FD-211

T36693-1g 1g Ask for price
Description: FD-211

FD-211

T36693-1mg 1mg Ask for price
Description: FD-211

FD-211

T36693-50mg 50mg Ask for price
Description: FD-211

FD-211

T36693-5mg 5mg Ask for price
Description: FD-211

FD-838

TN4053-10mg 10mg Ask for price
Description: FD-838

FD-838

TN4053-1g 1g Ask for price
Description: FD-838

FD-838

TN4053-1mg 1mg Ask for price
Description: FD-838

FD-838

TN4053-50mg 50mg Ask for price
Description: FD-838

FD-838

TN4053-5mg 5mg Ask for price
Description: FD-838

FD-211

MBS5797775-25mg 25(mg
EUR 1325

FD-211

MBS5797775-5x25mg 5x25(mg
EUR 5815

FD223

HY-132231 10 mg
EUR 1569.29
Description: FD223 is a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor. FD223 displays high potency (IC50=1 nM) and good selectivity over other isoforms (IC50s of 51 nM, 29 nM and 37 nM, respectively for α, β and γ). FD223 exhibits efficient inhibition of the proliferation of acute myeloid leukemia (AML) cell lines by suppressing p-AKT Ser473 thus causing G1 phase arrest during the cell cycle. FD223 has potential for the research of leukemia such as AML[1].

FD274

HY-155066 Get quote Ask for price
Description: FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1].

Recombinant Uncharacterized membrane protein F35D11.3 (F35D11.3)

MBS7040907-002mg 0.02mg
EUR 1990

Recombinant Uncharacterized membrane protein F35D11.3 (F35D11.3)

MBS7040907-01mg 0.1mg
EUR 2920